ECYT : Summary for Endocyte, Inc. - Yahoo Finance

U.S. Markets closed

Endocyte, Inc. (ECYT)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.63-0.02 (-0.75%)
At close: 4:00 PM EST

2.63 0.00 (0.00%)
After hours: 4:40 PM EST

People also watch:
ACRXINFIAEGREPZMMACK
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close2.65
Open2.67
Bid2.55 x 6000
Ask3.15 x 3000
Day's Range2.62 - 2.70
52 Week Range2.55 - 4.47
Volume134,838
Avg. Volume171,655
Market Cap111.17M
Beta1.38
PE Ratio (TTM)-2.60
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswireyesterday

    Endocyte to Present at the IASLC 17th World Conference on Lung Cancer

    WEST LAFAYETTE, Ind., Dec. 01, 2016-- Endocyte, Inc., a leader in developing targeted small molecule drug conjugates and companion imaging agents for personalized therapy, today announced that data from ...

  • Capital Cube3 days ago

    ETFs with exposure to Endocyte, Inc. : November 29, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Endocyte, Inc. Here are 5 ETFs with the largest exposure to ECYT-US. Comparing the performance and risk of Endocyte, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Endocyte, Inc. :ECYT-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016
    Capital Cube4 days ago

    Endocyte, Inc. :ECYT-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016

    Categories: Yahoo Finance Get free summary analysis Endocyte, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Endocyte, Inc. – Amgen Inc., Johnson & Johnson, Merck & Co., Inc., Nektar Therapeutics, General Electric Company, Tetralogic Pharmaceuticals Corporation, Cerulean Pharma, Inc., AbbVie, Inc. and Verastem, Inc. (AMGN-US, ... Read more (Read more...)